113
views
0
recommends
+1 Recommend
0 collections
    4
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene in lung cancers are associated with increased sensitivity of these cancers to drugs that inhibit EGFR kinase activity. However, the role of such mutations in the pathogenesis of lung cancers is unclear.

          Related collections

          Author and article information

          Journal
          J Natl Cancer Inst
          Journal of the National Cancer Institute
          Oxford University Press (OUP)
          1460-2105
          0027-8874
          Mar 02 2005
          : 97
          : 5
          Affiliations
          [1 ] Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-8593, USA.
          Article
          97/5/339
          10.1093/jnci/dji055
          15741570
          24386d41-f43b-41e2-a5f8-0f2e3dfe0e45
          History

          Comments

          Comment on this article